Skip to content

Clinical trials

Withdrawn trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Status: Withdrawn Country / region: Serbia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20173
20201
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
University of Belgrade2
Alnylam Pharmaceuticals1
Bristol-Myers Squibb1
Cardiawave SA1
Celgene1
Clinical Hospital Center Zemun1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 22
Aortic Valve Stenosis1
Atypical Hemolytic Uremic Syndrome1
Crohn Disease1
Giant Cell Arteritis1
Hemolysis1
Lymphoma, Follicular1
Major Depressive Disorder1
Renal Insufficiency1
Thrombocytopenia1

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.